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Abstract
Background: Methadone maintenance treatment (MMT) has been scaled up by the Chinese government alongside
persistent compulsory drug user detention, but the extent to which detention interferes with MMT is unknown. The
study systematically reviews Chinese MMT retention rates, reasons for drop out, and behavioural changes.
Method: Chinese and English databases of literature are searched for studies reporting retention rates, drug use and
sexual behaviours among MMT participants in China between 2004 and 2013. The estimates are summarized
through a systematic review and meta-analysis.
Results: A total of 74 studies representing 43,263 individuals are included in this analysis. About a third of MMT
participants drop out during the first three months of treatment (retention rate 69.0% (95% CI 57.7-78.4%)). Police
arrest and detention in compulsory rehabilitation was the most common cause of drop out, accounting for 22.2% of
all those not retained. Among retained participants, changing unsafe drug use behaviours was more effective than
changing unsafe sexual behaviours. At 12 months following MMT initiation, 24.6% (15.7-33.5%) of MMT participants
had a positive urine test, 9.3% (4.7-17.8%) injected drugs and only 1.1% (0.4-3.0%) sold sex for drugs. These
correspond to 0.002 (<0.001-0.011), 0.045 (0.004-0.114) and 0.209 (0.076-0.580) times lower odds than baseline.
However, MMT participants did not have substantial changes in condom use rates.
Conclusion: MMT is effective in drug users in China but participant retention is poor, substantially related to
compulsory detention. Reforming the compulsory drug user detention system may improve MMT retention and
effectiveness.
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Introduction
Since 1979 the illicit drug trade has prominently re-emerged
in China [1], contributing to a substantial burden of drug-
associated disease. The number of registered drug users in
China increased 19-fold between 1990 and 2009 [1].
Intravenous injection is the most common means of drug use,
with injecting drug users (IDUs) accounting for 59-85% of drug
users in China [2,3,4,5,6,7,8]. The high injection frequency,
sharing of contaminated needles and other risk behaviours
[9,10,11] [12,13] among IDUs accelerate the spread of HIV
infection. The cumulative number of diagnosed HIV/AIDS
cases in China is now well over 200,000, among which over
60% are drug users [14,15], and new infections among IDUs
accounts for 17% of new HIV cases in 2011 [16].
Responding to the growing IDU HIV epidemic in China,
domestic and international programs launched harm reduction
programs in 2003 [17,18,19]. A major component of harm
reduction is methadone maintenance treatment (MMT), a
substitution program known to reduce morbidity, a mortality
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[20,21] and risk of HIV infection in drug users [22]. China
launched pilot MMT programs in 8 clinics serving 1,029 drug
users in 2004 and subsequently expanded to 738 clinics
serving 344,254 drug users by the end of 2011. Now MMT
reaches approximately 30% of registered IDUs in China
(personal communication with China CDC). MMT services
focus on decreasing drug use and sexual risk behaviours,
including counselling and HIV testing [23]. However, MMT
services in China are closely monitored by the public security.
Police raids and arrests near MMT sites are common, and
MMT participants who have positive urine tests will be sent for
compulsory detention and rehabilitation [23,24,25]. During and
following detention and rehabilitation, access to MMT services
is limited [24]. At places where the police is cooperative with
the local CDC, participation and intervention outcomes in MMT
participants are generally better [26].
While several studies have reported retention rates and
behavioural outcomes in MMT participants
[14,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,
46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,
66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,
86,87,88,89,90,91,92,93,94,95,96,97,98,99], these studies
have not been systematically reviewed and integrated to
provide an overall assessment of the effectiveness of MMT
programs in China [100,101]. Drop-out rates in MMT clinics are
perceived to be high as approximately 50-70% participants
terminate treatment within three month of their enrolment in
China. Poor retention, administrative detention, and other
structural factors may obscure the effect of MMT on durable
behaviour change [102,103]. This study systematically
investigates overall retention rates, reasons for dropout, drug
use behaviour changes, and sexual behaviour changes at
Chinese MMT clinics.
Methods
Search strategy
Two independent investigators (EPFC and XZ) conducted a
systematic review of published peer-reviewed research articles
by searching the following databases between January 2004
and April 2013: PubMed, Chinese Scientific Journals Fulltext
Database (CQVIP), China National Knowledge Infrastructure
(CNKI) and Wanfang Data. We performed two separate search
strategies for (1) retention rates and reasons for dropout; and
(2) behavioural changes attributable to MMT services. This
review was reported according to the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-Analyses)
Statement issued in 2009 [30] (Checklist S1). The search
strategy was detailed in Supplementary Text S1.
Study selection
Studies were eligible for inclusion in this systematic review if
they met all following criteria: (1) study published in Chinese or
English language; (2) study reported the drug and sexual
behavioural changes before and after entering MMT clinics; (3)
study reported percentage of retention rate among the MMT
participants; (4) study reported reasons for dropout; and (5)
study reported study site, time period and sample size.
Intervention studies were selected, but only the control groups
among MMT participants were included. Exclusion criteria
were: (1) review papers; (2) non peer-reviewed local/
government reports; (3) conference abstracts and
presentations; (4) dissertations; (5) studies reported baseline or
follow-up data only. If the same study data were published in
both English and Chinese sources, the articles published in
Chinese language journals were excluded from this study. A
MMT participant was considered as ‘drop-out’ if he/she failed to
attend the enrolled MMT clinic for seven consecutive days
without providing a reason. All MMT clinics in China were
under the supervision of China CDC and adapted the same
definition of retention.
Validity assessment
The quality of studies was assessed using a validated quality
assessment tool [31]. The following eight items were assessed
to calculate a total quality score: (1) clear definition of the target
population; (2) representativeness of probability sampling; (3)
sample characteristics matching the overall population; (4)
adequate response rate; (5) standardised data collection
methods; (6) reliability of survey measures/instruments; (7)
validity of survey measures/instruments; (8) appropriate
statistical methods. Answers were scored 0 and 1 for ‘No’ and
‘Yes’, respectively. The total quality score varied between 0
and 8 for each study.
Data abstraction
We extracted the following information from all eligible
studies: published year, study location, study period, age and
sex composition of the sample, percentage married, level of
education, study design, methods of recruitment and sample
size at recruitment as the demographic indictors. We extracted
the following behavioural change data for the pre-MMT and
post-MMT periods: injecting drug in the past month, sharing
needles in the past month, percentage who sell sex for drugs in
the past three months, and the rate of consistent condom use
during any sexual intercourse in the past month. Additionally,
we extracted data on the retention rate of the MMT participants
at several follow-up points, and the reasons for drop out. An
individual was considered ‘dropped-out’ if they did not attend
an MMT clinic for seven consecutive days.
Statistical analysis
Meta-analyses were carried out with the Comprehensive
Meta-Analysis software (V 2.0, Biostat, Englewood, New
Jersey) [104]. The principal summary measures, including the
effect rates of pooled prevalence estimates, odd ratios and
their 95% confidence intervals (CIs) were determined based on
random effect models. Random effect models were applied
when heterogeneity across subgroups were found to be
significant [105]. Heterogeneity tests were performed using the
Cochran Q-test (p<0.10 represents statistically significant
heterogeneity) and the I2 statistic [106,107,108]. We
investigated the factors that are associated with
heterogeneities in the stratified meta-analyses using meta-
regression [109]. Meta-regression was performed in STATA
statistical software package (Version 10, StataCorp, College
MMT Effectiveness in China
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Station, TX). Potential publication bias was measured by the
Begg and Mazumdar rank correlation (p<0.05) [110,111].
Results
A total of 495 and 650 potentially relevant studies on MMT
retention and behavioural changes, respectively, among drug
users after MMT intervention were identified. A total of 56
[14,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,
46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,
66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81] (Figure S1)
and 28
[30,34,37,44,49,50,62,63,64,81,82,83,84,85,86,87,88,89,90,91,
92,93,94,95,96,97,98,99] studies (Figure S2) were
subsequently eligible and selected for analyses, respectively.
Retention in MMT
Twenty-seven studies reported retention rate among MMT
participants (Table S1). The retention rates at one, three, six,
12, and 24 months after enrolment were 89.4% (95% CI,
85.6-92.3%), 69.0% (57.7-78.4%), 62.9 (55.3-69.9%), 55.2
(48.5-61.7%) and 43.0% (34.7-51.7%) (Figure 1). Notably,
most drop outs occur in the first three months. MMT retention
rates decrease less than 10% in the following 21 month period.
Forty-three studies (20,873 studies participants) reported
reasons for drop out from MMT in China (Table S2). Among the
drop-outs, about one-fourth of the participants (22.2%) were
arrested by police and sent to detention centres due to relapse
in drug use (positive urine test) during the course of MMT,
19.1% self-withdrew and 13.3% were due to relocation to
another city outside the clinic coverage. Other drop out reasons
such as criminal activities (7.6%), unregistered by the MMT
clinics (6.3%), death and sickness (6.3%) and dosage issues
(0.1%) were also reported (Figure 2).
Drug using behaviours among MMT participants
Nineteen studies reported changes in injecting behaviours
among MMT entrants after receiving MMT. Our analysis
showed that 82.3% (75.2-87.7%) of the MMT entrants injected
drugs in the past month at baseline and this significantly
reduced to 9.1% (4.5-17.6%) after six months of entry and
slightly increased to 9.3% (4.7-17.8%) after twelve months of
MMT intervention (Figure S3a). These correspond to 0.012
(0.004-0.033) and 0.045 (0.017-0.114) times lower odds of
injecting drug at six and twelve months after treatment
respectively (Figure 3a). However, MMT did not change drug
sharing behaviours among MMT participants (aOR = 0.531
[0.174-1.627] and 0.298 [0.017-5.100] for six and twelve
months intervention) (Figure 3b). An estimated 10.8%
(6.3-17.8%) of MMT participants shared syringes in the past
month, whereas 7.6% (2.8-18.9%) and 1.8% (0.2-12.7%) of the
MMT participants shared syringes after six and twelve months
intervention (Figure S3b).
Six studies reported proportion of positive urine tests among
MMT participants. At baseline, 92.6% (90.1-95.2%) of
participants had positive drug urine tests. The proportion
significantly dropped to 60.9% (53.5-68.3%), 50.8%
(53.5-68.3%) and 24.6 (15.7-33.5%) at three, six and twelve
months after enrolment in MMT (Table S3). These correspond
to 0.47 (0.03-8.29), 0.05 (0.01-0.24) and 0.002 (<0.001-0.011)
lower odds of positive urine testing compared with baseline.
Sexual behaviours among MMT participants
Six studies reported the changes in sexual behaviours
among MMT participants (Figure 3c). The consistent condom
use in past one month increased from 24.6% (20.2-29.5%) at
baseline level to 40.9% (18.7-67.6%) after 6 months of
intervention, although the increase was not significant (aOR =
2.036 [0.696-5.957]) (Figure S3c).
Eight studies examined the likelihood of selling sex for drugs
among MMT participants. Approximately 5.2% (2.5-10.3%) of
MMT participants had sold sex for drugs in the past three
months before receiving MMT intervention. This percentage
dropped to 1.1% (0.5-2.3%) and 1.1% (0.4-3.0%) after six-
month and 12-month post-intervention, respectively (Figure
S3d). MMT had a significant impact on reducing commercial
sex activities among drug users, as the odds of selling-sex in
the past three months reduced to 0.248 (0.111-0.553) and
0.209 (0.076-0.580) six and 12 months after intervention
(Figure 3d).
Heterogeneities and publication biases
Heterogeneities were observed in several sub-group meta-
analyses. In the meta-analyses of retention rate among MMT
participants, high and significant heterogeneities were detected
at 1 month (I2=96.3%, p<0.001), 3 months (I2=99.0%, p<0.001),
6 months (I2=98.4%, p<0.001), 12 months (I2=98.0%, p<0.001)
and 24 months (I2=98.6%, p<0.001) post-registration (Figure
1). Additionally, significant heterogeneities were also observed
in measuring the OR of the percentage of who injected after six
months (I2=97.2%, p<0.001) and twelve months (I2=94.1%,
p<0.001) of follow-up (Figure 3a); the OR of the percentage
who shared needles at six months follow-up (I2=87.8%,
p=0.002) (Figure 3b); the consistent condom use rate in the
past one month (I2=96.1%, p<0.001) after six-month follow-up
(Figure 2c); and the OR of the percentage of MMT participants
who sold sex for drug (I2=72.3%, p=0.013) after twelve months
follow-up (Figure 2d). Subsequent meta-regression suggested
that sampling size, publication language, study design, period
and location are not contributing factors to the observed high
heterogeneities. No publications biases were observed in all
meta-analyses performed. Of the full quality score of eight
points, the selected studies have a median score of 4
(Interquartile range: 3-5) (Table S1-2, 4).
Discussion
MMT is a key harm reduction strategy for improving the
health and well-being of drug users worldwide. To our
knowledge, this is the first systematic review of MMT
effectiveness in a nation with common detention practices. Our
analysis indicates that drop-out rates are high within the first
three months of enrolment, as more than one-third of the
participants discontinue their treatment. Retention increases
substantially in the next 21 months, with over half of the
participants remaining on treatment after 24 months. This
MMT Effectiveness in China
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Figure 1.  Retention of participants of MMT clinics in China.  
doi: 10.1371/journal.pone.0068906.g001
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Figure 2.  Major reasons of dropping-out from MMT clinics among 20,873 participants.  
doi: 10.1371/journal.pone.0068906.g002
Figure 3.  Changes in injecting behaviours among retained MMT participants.  (a) Likelihood of injecting drug use in the past
one month of Chinese MMT participants at six and twelve months follow-up.
(b) Likelihood of sharing injection equipment in the past one month among Chinese MMT-participating IDUs at six and twelve
months follow-up.
(c) Likelihood of having consistent condom use during in all sexual intercourses in the past one month among Chinese MMT
participants at 6 months follow-up.
(d) Likelihood of selling sex for drugs in the past three months among Chinese MMT participants at six and twelve months follow-up.
doi: 10.1371/journal.pone.0068906.g003
MMT Effectiveness in China
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demonstrates that participants who sustained the first three
months are likely to remain on treatment. The phenomenon of
early drop-out is consistent with findings in international
settings [112,113]. In comparison, the 12-month MMT retention
rate in China is substantially lower than programs in other
developed (60-85% [22,114,115,116]) and developing
countries settings (62-82% [117,118]).
The leading cause of MMT dropout (22.2%) was related to
relapse in drug use and compulsory police detention. Our
quantitative analysis extends previous qualitative literature
suggesting interference between detention and MMT in Asia
[102,103,119]. A recent 12 United Nation Joint Agency
Statement called for an end to compulsory detention, as
mandatory detention centres do not provide an effective
environment for treatment of drug dependence and constantly
violate internationally recognised human right standards [120].
Our results suggest that relapse and detention, self-
withdrawal, and mobility are major barriers to durable MMT
participant retention. The major reason for drop out is relapse
and compulsory detention. In China, the police are entitled to
request random urine tests for any suspected drug users.
During times to meet arrest quotas, police will act aggressively
toward drug users, especially those registered with MMT
program [25]. Relapsed drug users are sent to detention
centres. Detention centre confinement does not reduce unsafe
drug use behaviours [121,122,123] and as many as 95% of
IDUs relapse within one year of release from detention [124].
Access to general health care and harm reduction programs is
extremely limited in Chinese detention centres [24]. Our results
indicate that police arrest and forced detention of relapsing
drug users may be a major obstacle for MMT program in China
reaching its full potential in providing sustaining quality care for
its participants. Second, more than one-fifth of the drop-outs
choose to self-withdraw from the treatment. The self-perception
of substantial improvement of physical conditions and
alleviation of addictive symptoms during the early phase of
MMT may lead to a misconception about maintaining drug
abstinence without completing the course of treatment
[125,126]. . The high self-withdraw highlights the need for
improving necessary counselling services and peer support to
eliminate these misconceptions [48,52,125]. Third, high
mobility of MMT participants, reflected by their frequent
relocations, also significantly contributes to the interruption of
their treatment. This poses a great challenge to the current
fragmented administrative model of MMT, in which MMT clinics
in different administrative jurisdictions do not share the medical
and treatment records of their participants [38,125,127,128].
Addressing these structural issues is important for retaining
mobile drug users within the MMT system.
Our study found large reductions in drug-related risk
behaviours among retained MMT participants in China. These
findings are comparable to international research
[129,130,131,132,133], indicating that the MMT has been
effective in its core objective of reducing drug related risk.
Nevertheless, these results need to be interpreted with caution.
Individuals who relapse in China are more likely to be expelled
from MMT and detained, decreasing their future chance of
entering the MMT system. It may undermine the effectiveness
of the program as relapsing individuals represent a subgroup
with higher risks and needing the treatment the most. Notably,
among continuing IDUs, the sharing rate of injection equipment
did not change over the course of treatment, contradicting
findings in other international contexts
[129,130,131,134,135,136]. Further integration of MMT and
syringe exchange programs is needed to reap the full benefits
of harm reduction. The fact that MMT in China does not reduce
unprotected sexual acts is consistent with international findings
[137].
Several limitations in this study should be noted. First, our
data covers only 19 provinces that are disproportionately in the
south and south-western part of China. However, these regions
have a larger number of IDUs with greater HIV disease burden.
Although we systematically incorporated all available
operational data, there remain a large number of governmental
documents, community-level reports and other unpublished
data that have never been archived in any of the public
literature databases. For some indicators, the numbers of
available publications are quite limited and this may potentially
reduce the statistical power and accuracy of subsequent meta-
analysis. Second, many studies report a high drop-out rate
without indicating specific reasons (12.9% on average). Many
contributing factors to treatment drop-out, such as attitudes of
staff, under-dosing, costs of treatment, family support and
commitments, stigma of being on methadone, poor
psychosocial services, and ability for drop-out individuals to re-
enter treatment, are not reported in the published literature and
hence cannot be investigated. Third, only 0.1% of the drop-outs
report insufficient methadone dosage as one of the reasons for
leaving treatment [138]. International literature indicates that
adequate methadone dosage should be above 60mg/day to be
effective [128] and insufficient methadone dosage results in
lower retention rates [138]. Daily dosage among Chinese MMT
participants is substantially lower than this level and may have
a strong effect on retention rates [38,125].
Our review provides pooled evidence that MMT has been
effective in reducing drug-related risk behaviours among
Chinese drug users. It informs policies to further expand the
coverage and scope of MMT to provide better and more
comprehensive treatment services for its participants.
However, despite the 2008 revised Law on Drug Control
allowing drug users in China access to community-based
rehabilitation prior to compulsory detention [23], punitive
incarceration of drug users in China remains common
[139,140] and substantially impacts on participants’ retention.
Our research adds quantitative public evidence for ending
compulsory drug use detention, amplifying the recent UN joint
statement [120] calling for an end to compulsory drug user
detention. A recent pronouncement from the Chinese
government stated that the re-education through labour system
responsible for detaining drug users is likely to be reformed in
the coming year [141]. Implementation of community-based
rehabilitation in China and other states could substantially
improve the effectiveness of MMT.
MMT Effectiveness in China
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